Carotene-rich food

INTRODUCTION

Onychodystrophy refers to various abnormalities in nail morphology due to changes in the attach­ment of the nail plate, changes in nail surface or color. They are associated with a variety of con­ditions such as psoriasis, onychomycosis, lichen planus, alopecia areata, endocrine disorders, and drug photosensitivity, etc. Local contact with irritants and trauma are the most common causes, but chronic idiopathic onychodystrophy is often seen without any associated conditions. Treatment modalities include avoidance of predisposing causes and trauma, keeping nails short, and drug therapy such as topical and intralesional corticosteroid. Intralesional corticosteroid injection produces the most reliable results but the response is only temporary and severe pain upon injection prohibits its use. Other modalities do not yield consistent and reliable results.

Read the rest of this entry »

Cutaneous metastasis from neuroendocrine car­cinoma of visceral origin is rarely described. The primary sites of origin include the lungs, larynx, mediastinum, uterus, and thymus. Histologically, a rosette-like structure is regarded as the best marker for recognition of neuroendocrine differentiation and is described as a small and regular, oval or round lumina, deeply eosinophilic luminal surfaces, and the absence of or rare accumulation of non- mucous material but frequent apoptotic debris in the lumina. To confirm these neuroendocrine fea­tures, CD56, synaptophysin, neuron-specific enolase and chromagranin A were used as immuno- histochemical staining and cytokeratin 20 was used to differentiate from a Merkel cell carcinoma. However, tumor cells were stained with cytokeratin 20 in our case. Cytokeratin 20, a low molecular weight cytokeratin, is found in a variety of normal tissues, including intestinal epithelium, gastric epithelium, urothelium, and Merkel cells. Most neuroendocrine carcinomas do not express cyto- keratin 20, with the exception of Merkel cell carcinoma, and most colorectal adenocarcinomas express cytokeratin 20. Kato et al. reported a case of cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon, suggesting a link between colorectal neuroendocrine carcinoma and conven­tional adenocarcinoma. These considerations also supported the notion that the present case shares common immunophentypes with colorectal adeno- carcinoma.

Read the rest of this entry »

A 58-year-old man presented with 1-month history of several skin lesions on his scalp, which had started as a tiny skin-colored papule. This progressively enlarged to form a solitary 2 cm-sized tender tumor and several new lesions had de­veloped. He had a history of rectal neuroendocrine carcinoma with multiple hepatic metastases.

Read the rest of this entry »

Neuroendocrine tumor

INTRODUCTION

Neuroendocrine neoplasm have been described in virtually every organ where neuroendocrine cells are distributed throughout the body. It com­monly exhibits multiple lines of divergent differen­tiation. Metastatic neuroendocrine carcinoma from distant sites, such as lung, and colon are high degrade tumors with poor prognosis. Cutaneous metastatic neuroendocrine carcinoma must be differentiated from Merkel cell carcinoma by immunohistochemical stains. Cutaneous metastasis from neuroendocrine carcinoma of visceral origin is rarely described. Read the rest of this entry »

DFSP is an uncommon mesenchymal neoplasm originating in the dermis. About 1,000 cases have been reported since DFSP was first described. It usually occurs as an indurated plaque that slowly increases in size and develops multiple firm nodules. Rarely, the initial plaque may be atrophic or depressed, and this atrophic appearance may persist. Lambert et al first described 5 cases that resembled morphea or morpheaform BCC but showed typical DFSP on biopsy. They suggested that the term protuberans should be discarded from the name dermatofibrosarcoma protuberans. Atrophic DFSP is an uncommon clinical variant of DFSP. To our knowledge, there have been 31 reported cases of atrophic DFSP to date . While atrophic DFSP has a distinct clinical appearance, its epidemiology, histology and clinical behavior appear to be similar to the common protuberant type. Truncal involvement is seen in 79% of cases, and there is a slight female predominance (62%), with the average age of onset being 30 years. It presents as a large, irregularly outlined, tan to brownish depressed scar-like lesion with atrophic patch. It is generally asymptomatic, slow growing, and often benign appearance, thus diagnosis is frequently delayed (median delay 6 years) . It may be clinically confused with other atrophic or sclerotic dermato- logic conditions, such as morphea, anetoderma, morpheaform basal cell carcinoma, scar, and lym- phocytoma.

Read the rest of this entry »

A 33-year-old female presented with gray de­pressed atrophic lesion accompanying a skin-colored pea-sized nodule arising from it, and erythematous indurated plaque with intermittent itching and pricking on her upper back. She had first noticed an asymptomatic erythematous plaque 7 years ago. Later, a skin-colored nodule had developed on the left lateral rim of that lesion and other part became depressed with grayish discoloration. And then an erythematous indurated plaque newly developed below the preexisting lesion (Fig. 1).

Read the rest of this entry »

Dermatofibrosarcoma protuberans

INTRODUCTION

Dermatofibrosarcoma protuberans (DFSP) is a slow-growing, locally aggressive tumor marked by its high rate of local recurrence. It usually begins as a red-brown indurated plaque, and develops nodules slowly over many years. Rarely, the initial skin lesion may be atrophic or depressed, and may persist despite the advance stage of tumor. Atrophic DFSP is a rare variant of DFSP, which presents as a depressed violaceous scar-like lesion with atrophic patch. The biologic behavior and histologic charac­teristics of atrophic DFSP is identical to classical DFSP. Read the rest of this entry »

Pages: Prev 1 2 3 ...19 20 21 22 23 24 25 ...71 72 73 Next
top